Home › NDC Lookup › RxCUI directory › RxCUI 1811180

Icosapent ethyl 500 MG Oral Capsule — RxCUI 1811180

RxNorm drug concept · Semantic clinical drug
RxCUI 1811180 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 16 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1811180
Official nameIcosapent ethyl 500 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asicosapent ethyl 0.5 GM Oral Capsule
FDA products mapped15
Package NDCs mapped16
Reported Medicaid activity (SDUD)86,819 prescriptions · 46 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Icosapent Ethyl: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Icosapent ethyl is a highly purified omega-3 fatty acid that helps lower very high triglyceride levels in your blood. Depending on the specific product and your health situation, y...
  • What exactly does icosapent ethyl do, and why has my doctor prescribed it?
  • Take them twice a day with food — that's how they were used in all the clinical studies, and food helps your body absorb the medicine properly. Swallow the capsules whole every tim...
  • How should I take my icosapent ethyl capsules?
📖 Read our full Icosapent Ethyl guide →

🕸️ Concept Web — How Icosapent ethyl 500 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Icosapent ethyl 500 MG Oral Capsule RxCUI 1811180

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Icosapent ethyl 1304974
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Vascepa 1304980
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Icosapent ethyl Oral Capsule 1304978
    • Icosapent ethyl Oral Product 1304976
    • Icosapent ethyl Pill 1304977
    • Icosapent ethyl Oral Capsule [Vascepa] 1304982
    • Vascepa Oral Product 1304983
    • Vascepa Pill 1304984
    • Oral Capsule 316965
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Icosapent ethyl 500 MG SCDC · 1811179
  • Icosapent ethyl Oral Capsule SCDF · 1304978
  • Icosapent ethyl Oral Product SCDG · 1304976
  • Icosapent ethyl Pill SCDG · 1304977

Brand-Name Concepts

  • Icosapent ethyl 500 MG Oral Capsule [Vascepa] SBD · 1811182
  • Icosapent ethyl 500 MG [Vascepa] SBDC · 1811181
  • Icosapent ethyl Oral Capsule [Vascepa] SBDF · 1304982
  • Vascepa Oral Product SBDG · 1304983
  • Vascepa Pill SBDG · 1304984
  • Vascepa BN · 1304980

📦 FDA Products & Package NDCs

15 products · 16 package NDCs
16 package NDCs map to RxCUI 1811180 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00480-0126-49 240 CAPSULE, LIQUID FILLED in 1 BOTTLE (0480-0126-49) Icosapent Ethyl Teva Pharmaceuticals, Inc. 2022-09-09
00480-0127-89 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (0480-0127-89) Icosapent Ethyl Teva Pharmaceuticals, Inc. 2022-12-15
31722-0298-24 240 CAPSULE in 1 BOTTLE (31722-298-24) ICOSAPENT ETHYL Camber Pharmaceuticals, Inc. 2024-02-16
31722-0299-12 120 CAPSULE in 1 BOTTLE (31722-299-12) ICOSAPENT ETHYL Camber Pharmaceuticals, Inc. 2024-02-16
42806-0559-24 240 CAPSULE, LIQUID FILLED in 1 BOTTLE (42806-559-24) ICOSAPENT ETHYL EPIC PHARMA, LLC 2023-12-22
42806-0560-12 120 CAPSULE, LIQUID FILLED in 1 BOTTLE (42806-560-12) ICOSAPENT ETHYL EPIC PHARMA, LLC 2023-12-22
43598-0746-72 240 CAPSULE in 1 BOTTLE (43598-746-72) Icosapent Ethyl Dr. Reddy's Laboratories, Inc. 2023-04-17
52937-0001-20 120 CAPSULE in 1 BOTTLE (52937-001-20) Vascepa Amarin Pharma Inc. 2012-10-01
52937-0003-16 1 BLISTER PACK in 1 CARTON (52937-003-16) / 16 CAPSULE in 1... Vascepa Amarin Pharma Inc. 2016-09-16
52937-0003-40 240 CAPSULE in 1 BOTTLE (52937-003-40) Vascepa Amarin Pharma Inc. 2016-09-16
52937-0005-20 120 CAPSULE in 1 BOTTLE (52937-005-20) Vascepa Amarin Pharma Inc. 2025-12-05
52937-0101-08 1 BLISTER PACK in 1 CARTON (52937-101-08) / 8 CAPSULE in 1... Vascepa Amarin Pharma Inc. 2012-10-01
69238-2597-07 240 CAPSULE in 1 BOTTLE (69238-2597-7) Icosapent ethyl Amneal Pharmaceuticals LLC 2023-11-01
69238-2598-08 120 CAPSULE in 1 BOTTLE (69238-2598-8) Icosapent ethyl Amneal Pharmaceuticals LLC 2023-11-01
72865-0289-24 240 CAPSULE in 1 BOTTLE (72865-289-24) ICOSAPENT ETHYL XLCare Pharmaceuticals, Inc. 2024-02-16
72865-0290-12 120 CAPSULE in 1 BOTTLE (72865-290-12) ICOSAPENT ETHYL XLCare Pharmaceuticals, Inc. 2024-02-16
Observed labelers: Amarin Pharma Inc. (5) · Amneal Pharmaceuticals LLC (2) · Camber Pharmaceuticals, Inc. (2) · EPIC PHARMA, LLC (2) · Teva Pharmaceuticals, Inc. (2) · XLCare Pharmaceuticals, Inc. (2) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.